Tag Archives: business

Making Sense of US Health Reform: Some Points for the Perplexed

By William Looney | Published: April 7, 2010
The March 21 passage by Congress of the Patient Protection and Affordable Care Act provides at long last a rough blueprint for driving future commercial opportunities in the second-biggest industry sector of the world’s largest economy. With over 2,400 pages of text and a phase-in timetable that extends to 2019, it is prudent to invoke [...]
Posted in Op-Ed | Also tagged , , , , , , | 3 Comments

Upcoming Webcast: The Visibility Solution

By George Koroneos | Published: March 15, 2010
The Visibility Solution: Delivering an Accurate View of Clinical Operations Thursday, April 1, 2010 at 11:00 AM PT; 2:00 PM ET; 16:00 GMT This event focuses on our Clinical Trials solution with HighPoint Solutions and is designed to illustrate how pharma companies can reduce the risk and expense of the clinical trial process with better use of [...]
Posted in Webcast | Also tagged , , , , , , | Leave a comment

AstraZeneca to Slash 8,000 More Jobs (Updated 2/3/10)

By Oriana Schwindt | Published: January 28, 2010
Last year, AstraZeneca announced the elimination of some 15,000 jobs. Last Thursday, the London-based company revealed that it plans to lay off another 8,000 by 2014—this despite global revenue growth of 4 percent for 2009. Much of the drive for this addition labor sculpting stems from AZ’s desire to streamline its R&D; the company will focus [...]
Posted in Strategy | Also tagged , , , , , , , | 1 Comment

Novartis Names Jimenez CEO

By George Koroneos | Published: January 26, 2010
Novartis shocked investors on Tuesday morning when the Swiss-based firm announced that CEO Daniel Vasella would relinquish his post as CEO to Joe Jimenez while retaining his chairman of the board spot. According to a release, this move has been in the works since 2008 and lead to the restructuring of its management team. The executive [...]
Posted in Strategy | Also tagged , , , , | 2 Comments

JP Morgan Healthcare Conference Marked by Hesitant Optimism

By Pharm Exec | Published: January 13, 2010
Guest blog by Audrey S. Erbes, Principal, Erbes & Associates While last year’s meeting was dominated by the global economic crisis and its impact on the healthcare industry, this year’s presenters tried to give investors a glimmer of hope for better outcomes in the future. The fear that darkened moods of attendees in 2009 was gone [...]
Posted in Events, Guest Blog | Also tagged , , , , , | 1 Comment